Prime Impact Acquisition I - Quarter Report: 2022 September (Form 10-Q)
Table of Contents
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Cayman Islands |
98-1554335 | |
(State or other jurisdiction of incorporation) |
(IRS Employer Identification No.) | |
123 E San Carlos Street, Suite 12 San Jose, California |
95112 | |
(Address of principal executive offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Units, each consisting of one Class A ordinary share and one-third of a Warrant to acquire one Class A ordinary share |
PIAI.U |
The New York Stock Exchange | ||
Class A ordinary shares, par value $0.0001 per share |
PIAI |
The New York Stock Exchange | ||
Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 |
PIAI.W |
The New York Stock Exchange |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
Table of Contents
PRIME IMPACT ACQUISITION I
Quarterly Report on Form 10-Q
Table of Contents
Table of Contents
Item 1. |
Condensed Financial Statements. |
September 30, 2022 |
December 31, 2021 |
|||||||
(unaudited) |
||||||||
Assets |
||||||||
Current assets: |
||||||||
Cash |
$ | 248,118 | $ | 665,940 | ||||
Prepaid expenses |
28,741 | 110,626 | ||||||
|
|
|
|
|||||
Total current assets |
276,859 | 776,566 | ||||||
Cash and Investments held in Trust Account |
69,405,841 | 324,211,180 | ||||||
|
|
|
|
|||||
Total Assets |
$ |
69,682,700 |
$ |
324,987,746 |
||||
|
|
|
|
|||||
Liabilities, Class A Ordinary Shares Subject to Redemption and Shareholders’ Deficit |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 346,131 | $ | 327,477 | ||||
Accrued expenses |
874,215 | 159,535 | ||||||
Convertible promissory note |
1,087,067 | — | ||||||
|
|
|
|
|||||
Total current liabilities |
2,307,413 | 487,012 | ||||||
Derivative warrant liabilities |
991,435 | 8,922,920 | ||||||
Deferred underwriting commissions |
11,342,945 | 11,342,945 | ||||||
|
|
|
|
|||||
Total Liabilities |
14,641,793 | 20,752,877 | ||||||
Commitments and Contingencies |
||||||||
Class A ordinary shares subject to possible redemption, $0.0001 par value; 6,794,168 and 32,408,414 shares issued and outstanding at approximately $10.20 and $10.00 per share redemption value as of September 30, 2022 and December 31, 2021, respectively |
69,305,841 | 324,084,140 | ||||||
Shareholders’ Deficit: |
||||||||
Preference shares, $0.0001 par value; 1,000,000 shares authorized; no shares issued or outstanding |
— | — | ||||||
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; no non-redeemable shares issued or outstanding |
— | — | ||||||
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 8,102,103 shares issued and outstanding as of September 30, 2022 and December 31, 2021 |
810 | 810 | ||||||
Additional paid-in capital |
— | — | ||||||
Accumulated deficit |
(14,265,744 | ) | (19,850,081 | ) | ||||
|
|
|
|
|||||
Total Shareholders’ Deficit |
(14,264,934 | ) | (19,849,271 | ) | ||||
|
|
|
|
|||||
Total Liabilities, Class A Ordinary Shares Subject to Redemption and Shareholders’ Deficit |
$ |
69,682,700 |
$ |
324,987,746 |
||||
|
|
|
|
For the Three Months Ended September 30, |
For the Nine Months Ended September 30, |
|||||||||||||||
2022 |
2021 |
2022 |
2021 |
|||||||||||||
|
|
|
|
|
|
|
|
|||||||||
General and administrative expenses |
$ | 798,038 | $ | 102,337 | $ | 1,143,084 | $ | 766,372 | ||||||||
Administrative expenses - related party |
30,000 | 30,000 | 90,000 | 90,000 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss from operations |
(828,038 | ) | (132,337 | ) | (1,233,084 | ) | (856,372 | ) | ||||||||
Other income (expense) |
||||||||||||||||
Change in fair value of derivative warrant liabilities |
— | 4,957,178 | 7,931,485 | 14,058,126 | ||||||||||||
Interest income |
10 | 19 | 43 | 96 | ||||||||||||
Income from investments held in Trust Account |
1,137,152 | 4,172 | 1,597,709 | 33,670 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income |
$ |
309,124 |
$ |
4,829,032 |
$ |
8,296,153 |
$ |
13,235,520 |
||||||||
Weighted average Class A ordinary shares outstanding, basic and diluted |
28,232,178 | 32,408,414 | 31,001,038 | 32,408,414 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted net income per Class A ordinary share |
$ | 0.01 | $ | 0.12 | $ | 0.21 | $ | 0.33 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Weighted average Class B ordinary shares outstanding, basic and diluted |
8,102,103 | 8,102,103 | 8,102,103 | 8,102,103 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted net income per Class B ordinary share |
$ | 0.01 | $ | 0.12 | $ | 0.21 | $ | 0.33 | ||||||||
|
|
|
|
|
|
|
|
Ordinary Shares |
Additional Paid-in Capital |
Accumulated Deficit |
Total Shareholders’ Deficit |
|||||||||||||||||||||||||
Class A |
Class B |
|||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance - December 31, 2021 |
— |
$ |
— |
8,102,103 |
$ |
810 |
$ |
— |
$ |
(19,850,081 |
) |
$ |
(19,849,271 |
) | ||||||||||||||
Net income |
— | — | — | — | — | 4,694,591 | 4,694,591 | |||||||||||||||||||||
Increase in redemption value of Class A ordinary shares subject to redemption |
— | — | — | — | — | (57,864 | ) | (57,864 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - March 31, 2022 (unaudited) |
— |
$ |
— |
8,102,103 |
$ |
810 |
$ |
— |
$ |
(15,213,354 |
) |
$ |
(15,212,544 |
) | ||||||||||||||
Net income |
— | — | — | — | — | 3,292,438 | 3,292,438 | |||||||||||||||||||||
Increase in redemption value of Class A ordinary shares subject to redemption |
— | — | — | — | — | (429,734 | ) | (429,734 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - June 30, 2022 (unaudited) |
— |
$ |
— |
8,102,103 |
$ |
810 |
$ |
— |
$ |
(12,350,650 |
) |
$ |
(12,349,840 |
) | ||||||||||||||
Net income |
— | — | — | — | — | 309,124 | 309,124 | |||||||||||||||||||||
Increase in redemption value of Class A ordinary shares subject to redemption |
— | — | — | — | — | (2,224,218 | ) | (2,224,218 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - September 30, 2022 (unaudited) |
— |
$ |
— |
8,102,103 |
$ |
810 |
$ |
— |
$ |
(14,265,744 |
) |
$ |
(14,264,934 |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary Shares |
Additional Paid-in Capital |
Accumulated Deficit |
Total Shareholders’ Deficit |
|||||||||||||||||||||||||
Class A |
Class B |
|||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance - December 31, 2020 |
— |
$ |
— |
8,102,103 |
$ |
810 |
$ |
— |
$ |
(35,618,082 |
) |
$ |
(35,617,272 |
) | ||||||||||||||
Net income |
— | — | — | — | — | 11,514,237 | 11,514,237 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - March 31, 2021 (unaudited) |
— |
$ |
— |
8,102,103 |
$ |
810 |
$ |
— |
$ |
(24,103,845 |
) |
$ |
(24,103,035 |
) | ||||||||||||||
Net loss |
— | — | — | — | — | (3,107,749 | ) | (3,107,749 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - June 30, 2021 (unaudited) |
— |
$ |
— |
8,102,103 |
$ |
810 |
$ |
— |
$ |
(27,211,594 |
) |
$ |
(27,210,784 |
) | ||||||||||||||
Net income |
— | — | — | — | — | 4,829,032 | 4,829,032 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - September 30, 2021 (unaudited) |
— |
$ |
— |
8,102,103 |
$ |
810 |
$ |
— |
$ |
(22,382,562 |
) |
$ |
(22,381,752 |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine Months Ended September 30, |
||||||||
2022 |
2021 |
|||||||
Cash Flows from Operating Activities: |
||||||||
Net income |
$ | 8,296,153 | $ | 13,235,520 | ||||
Adjustments to reconcile net income to net cash used in operating activities: |
||||||||
Change in fair value of derivative warrant liabilities |
(7,931,485 | ) | (14,058,126 | ) | ||||
Net income from investments held in Trust Account |
(1,597,709 | ) | (33,670 | ) | ||||
Changes in operating assets and liabilities: |
||||||||
Prepaid expenses |
81,885 | 186,847 | ||||||
Accounts payable |
18,654 | 194,971 | ||||||
Accrued expenses |
714,680 | (3,529 | ) | |||||
|
|
|
|
|||||
Net cash used in operating activities |
(417,822 | ) | (477,987 | ) | ||||
|
|
|
|
|||||
Cash Flows from Investing Activities: |
||||||||
Cash deposited in Trust Account for extension |
(1,087,067 | ) | — | |||||
Cash withdrawn from Trust Account for redemptions |
257,490,115 | — | ||||||
|
|
|
|
|||||
Net cash provided by investing activities |
256,403,048 | — | ||||||
|
|
|
|
|||||
Cash Flows from Financing Activities: |
||||||||
Loan proceeds received from convertible note payable to Sponsor |
1,087,067 | — | ||||||
Repayment of advances from related party |
— | (418,317 | ) | |||||
Redemption of Class A ordinary shares |
(257,490,115 | ) | — | |||||
|
|
|
|
|||||
Net cash used in financing activities |
(256,403,048 | ) | (418,317 | ) | ||||
|
|
|
|
|||||
Net change in cash |
(417,822 | ) | (896,304 | ) | ||||
Cash - beginning of the period |
665,940 | 1,600,255 | ||||||
|
|
|
|
|||||
Cash - end of the period |
$ |
248,118 |
$ |
703,951 |
||||
|
|
|
|
• | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
• | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
For the Three Months Ended September 30, |
||||||||||||||||
2022 |
2021 |
|||||||||||||||
Class A |
Class B |
Class A |
Class B |
|||||||||||||
Basic and diluted net income per ordinary share: |
||||||||||||||||
Numerator: |
||||||||||||||||
Allocation of net income available to ordinary shareholders |
$ | 240,193 | $ | 68,931 | $ | 3,863,226 | $ | 965,806 | ||||||||
Denominator: |
||||||||||||||||
Basic and diluted weighted average ordinary shares outstanding |
28,232,178 | 8,102,103 | 32,408,414 | 8,102,103 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted net income per common share |
$ | 0.01 | $ | 0.01 | $ | 0.12 | $ | 0.12 | ||||||||
|
|
|
|
|
|
|
|
For the Nine Months Ended September 30, |
||||||||||||||||
2022 |
2021 |
|||||||||||||||
Class A |
Class B |
Class A |
Class B |
|||||||||||||
Basic and diluted net income per ordinary share: |
||||||||||||||||
Numerator: |
||||||||||||||||
Allocation of net income available to ordinary shareholders |
$ |
6,577,204 |
$ |
1,718,949 |
$ |
10,588,416 |
$ |
2,647,104 |
||||||||
Denominator: |
||||||||||||||||
Basic and diluted weighted average ordinary shares outstanding |
31,001,038 |
8,102,103 |
32,408,414 |
8,102,103 |
||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted net income per common share |
$ |
0.21 |
$ |
0.21 |
$ |
0.33 |
$ |
0.33 |
||||||||
|
|
|
|
|
|
|
|
• | in whole and not in part; |
• | at a price of $0.01 per warrant; |
• | upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and |
• | if, and only if, the last reported sales price (the “closing price”) of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders (the “Reference Value”). |
• | in whole and not in part; |
• | at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the “fair market value” of the Class A ordinary shares; |
• | if, and only if, the Reference Value equals or exceeds $10.00 per Public Share (as adjusted per share sub-divisions, share dividends, reorganizations, recapitalizations and the like); and |
• | if the Reference Value is less than $18.00 per share (as adjusted for share sub-divisions, share dividends, rights issuances, sub-divisions, reorganizations, recapitalizations and the like), then the Private Placement Warrants must also concurrently be called for redemption on the same terms as the outstanding Public Warrants as described above. |
Gross proceeds |
$ | 324,084,140 | ||
Less: |
||||
Amount allocated to Public Warrants |
(12,955,337 | ) | ||
Class A ordinary shares issuance costs |
(17,680,825 | ) | ||
Plus: |
||||
Accretion of carrying value to redemption value |
30,636,162 | |||
|
|
|||
Class A ordinary shares subject to possible redemption, December 31, 2021 |
324,084,140 | |||
Plus: |
||||
Increase in redemption value of Class A ordinary shares subject to redemption due to extension |
1,087,067 | |||
Increase in redemption value of Class A ordinary shares subject to redemption |
1,624,749 | |||
Less: |
||||
Redemption of Class A ordinary shares subject to redemption |
(257,490,115 | ) | ||
|
|
|||
Class A ordinary shares subject to possible redemption, September 30, 2022 |
$ | 69,305,841 | ||
|
|
As of September 30, 2022 |
||||||||||||
Description |
Quoted Prices in Active Markets (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Other Unobservable Inputs (Level 3) |
|||||||||
Liabilities: |
||||||||||||
Derivative warrant liabilities-Public warrants |
$ | 648,168 | $ | — | $ | — | ||||||
Derivative warrant liabilities-Private placement warrants |
$ | — | $ | — | $ | 343,267 |
As of December 31, 2021 |
||||||||||||
Description |
Quoted Prices in Active Markets (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Other Unobservable Inputs (Level 3) |
|||||||||
Assets: |
||||||||||||
Investments held in Trust Account |
$ | 324,211,180 | $ | — | $ | — | ||||||
Liabilities: |
||||||||||||
Derivative warrant liabilities—Public warrants |
$ | 5,833,514 | $ | — | $ | — | ||||||
Derivative warrant liabilities—Private placement warrants |
$ | — | $ | — | $ | 3,089,406 |
September 30, 2022 |
December 31, 2021 |
|||||||
Exercise price |
$ | 11.50 | $ | 11.50 | ||||
Stock price |
$ | 10.06 | $ | 9.84 | ||||
Volatility |
5.4 | % | 9.3 | % | ||||
Term |
5.46 | 5.58 | ||||||
Risk-free rate |
3.96 | % | 1.30 | % | ||||
Dividend yield |
0.0 | % | 0.0 | % | ||||
Implied probability of success |
6.1 | % | N/A |
2022 |
2021 |
|||||||
Level 3 derivative warrant liabilities at January 1, |
$ | 3,089,406 | $ | 9,096,584 | ||||
Change in fair value of derivative warrant liabilities |
(1,716,337 | ) | (4,348,053 | ) | ||||
|
|
|
|
|||||
Level 3 derivative warrant liabilities at March 31, |
1,373,069 | 4,748,531 | ||||||
Change in fair value of derivative warrant liabilities |
(1,029,802 | ) | 972,591 | |||||
|
|
|
|
|||||
Level 3 derivative warrant liabilities at June 30, |
343,267 | 5,721,122 | ||||||
Change in fair value of derivative warrant liabilities |
— | (1,716,337 | ) | |||||
|
|
|
|
|||||
Level 3 derivative warrant liabilities at September 30, |
$ | 343,267 | $ | 4,004,785 | ||||
|
|
|
|
Table of Contents
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
References to the “Company,” “Prime Impact Acquisition I,” “Prime Impact,” “our,” “us” or “we” refer to Prime Impact Acquisition I. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited interim condensed financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Exchange Act of 1934 (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other U.S. Securities and Exchange Commission (the “SEC”) filings.
Overview
We are a blank check company incorporated as a Cayman Islands exempted company on July 21, 2020. We were formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). We are an emerging growth company and, as such, we are subject to all of the risks associated with emerging growth companies.
Our sponsor is Prime Impact Cayman, LLC, a Cayman Islands limited liability company (the “Sponsor”). The registration statement for the initial public offering was declared effective on September 9, 2020 (the “Initial Public Offering”). On September 14, 2020, we consummated the Initial Public Offering of 30,000,000 units (each, a “Unit” and collectively, the “Units” and, with respect to the Class A ordinary shares included in the Units, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $300.0 million, and incurring offering costs of approximately $17.1 million, inclusive of approximately $10.5 million in deferred underwriting commissions. The underwriters were granted a 45-day option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 4,500,000 additional Units to cover over-allotments, if any, at $10.00 per Unit. On October 2, 2020, the underwriters partially exercised the over-allotment option to purchase an additional 2,408,414 units (the “Over-Allotment Units”). On October 6, 2020, we completed the sale of the Over-Allotment Units to the underwriters (the “Over-Allotment”), generating gross proceeds of approximately $24.1 million, and incurring additional offering costs of approximately $1.3 million in underwriting fees (inclusive of approximately $0.8 million in deferred underwriting commissions).
Simultaneously with the closing of the Initial Public Offering, we consummated the private placement (“Private Placement”) of 5,400,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) to the Sponsor, each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.50 per Private Placement Warrant, generating gross proceeds to us of $8.1 million. Simultaneously with the closing of the Over-allotment Units, on October 6, 2020, we consummated the second closing of the Private Placement, resulting in the purchase of an additional 321,122 Private Placement Warrants by the Sponsor, generating gross proceeds to us of approximately $0.5 million.
21
Table of Contents
Upon the closing of the Initial Public Offering and the Private Placement, $324.1 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering, the Over-Allotment and certain of the proceeds of the Private Placement were placed in a trust account (“Trust Account”) with Continental Stock Transfer & Trust Company acting as trustee and was invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended, or the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by us, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.
Our management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. Our initial Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting discount) at the time we sign a definitive agreement in connection with the initial Business Combination. However, we will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.
On September 13, 2022, we held an extraordinary general meeting of shareholders (the “General Meeting”) to consider and vote upon a proposal to amend the Company’s amended and restated memorandum and articles of association to: (i) extend from September 14, 2022 to December 14, 2022, the date (the “Termination Date”) by which, if we have not consummated a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination involving one or more businesses or entities, the we must: (a) cease all operations except for the purpose of winding up; (b) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares; and (c) as promptly as reasonably possible following such redemption liquidate and dissolve, subject in each case to its obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of applicable law, provided that the Sponsor (or its affiliates or permitted designees) deposits an amount into the Trust Account equal to the lesser of (A) US$1,120,000 or (B) $0.16 for each Public Share that is not redeemed in connection with the General Meeting, in exchange for one or more non-interest bearing, unsecured promissory notes issued by the Company to the Sponsor (or its affiliates or permitted designees), and (ii) in the event that the Company has not consummated an initial Business Combination by December 14, 2022, without further approval of the Company’s shareholders, to allow the Company, by resolution of the board of directors of the Company if requested by the Sponsor, and upon five days’ advance notice prior to the applicable Termination Date to extend the Termination Date up to three times, each by one additional month (for a total of up to three additional months to complete a Business Combination), provided that the Sponsor (or its affiliates or permitted designees) will deposit into the Trust Account: (I) for the first such monthly extension, the lesser of (a) US$385,000 or (b) $0.055 for each Public Share that is not redeemed in connection with the General Meeting; (II) for the second such monthly extension, the lesser of (a) US$385,000 or (b) $0.055 for each Public Share that is not redeemed in connection with the General Meeting; and (III) for the third such monthly extension, the lesser of (a) US$385,000 or (b) $0.055 for each Public Share that is not redeemed in connection with the General Meeting, for an aggregate deposit of up to the lesser of: (x) $1,155,000 or (y) US$0.165 for each Public Share that is not redeemed in connection with the General Meeting, in exchange for one or more non-interest bearing, unsecured promissory notes issued by the Company to the Sponsor (or its affiliates or permitted designees). If the Company completes its initial Business Combination, it will, at the option of the Sponsor (or its affiliates or permitted designees), repay the amounts loaned under the promissory note(s) or convert a portion or all of the amounts loaned under such promissory note(s) into warrants at a price of $1.50 per warrant, which warrants will be identical to the private placement warrants issued to the Sponsor at the time of the Company’s initial public offering. If the Company does not complete a Business Combination by the deadline to consummate an initial Business Combination, such promissory notes will be repaid only from funds held outside of the Trust Account. On September 13, 2022 the shareholders voted to approve the extension proposal. In connection with the extraordinary general meeting and vote to extend the Termination Data, shareholders elected to redeem 25,614,246 Public Shares. Following such redemptions, approximately $69.4 million remains in the Trust Account and 6,794,168 Public Shares remain issued and outstanding.
If we are unable to complete a Business Combination by the Termination Date, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any) and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject, in the case of clauses (ii) and (iii), to our obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of applicable law.
22
Table of Contents
Liquidity and Going Concern
As of September 30, 2022, we had approximately $248,000 in our operating bank account and working capital deficit of approximately $2.0 million.
Prior to the completion of the Initial Public Offering, our liquidity needs had been satisfied through the payment of $25,000 from the Sponsor to cover certain expenses in exchange for the issuance of Class B ordinary shares and a loan of approximately $98,000 pursuant to a promissory note issued to the Sponsor. We repaid the promissory note in full on September 16, 2020. Subsequent to the consummation of the Initial Public Offering and Private Placement, our liquidity needs have been satisfied with the proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, in September 2022, our Sponsor agreed to loan us up to $1,500,000, a portion of which is to be used to fund the extension deposit made to the Trust Account.
In connection with our assessment of going concern considerations in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 205-40, “Presentation of Financial Statements-Going Concern,” our management has determined that the mandatory liquidation date and subsequent dissolution raises substantial doubt about our ability to continue as a going concern. If we are unable to complete a business combination by December 14, 2022, then we will cease all operations except for the purpose of liquidating. We have the option to extend the deadline by three successive one-month increments by making extension payments into the Trust Account through an additional extension loan from our Sponsor. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate after December 14, 2022. Our management plans to continue its efforts to complete a Business Combination by December 14, 2022. We believe that the funds currently available to us outside of the Trust Account will be sufficient to allow us to operate until December 14, 2022; however, there can be no assurances that this estimate is accurate.
Management continues to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on our financial position, results of our operations and/or search for a target company, the specific impact is not readily determinable as of the date of the condensed financial statements. The condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Results of Operations
Our entire activity since inception through September 30, 2022, related to our formation, the preparation for the Initial Public Offering, and since the closing of the Initial Public Offering, the search for a prospective initial Business Combination. We have neither engaged in any operations nor generated any revenues to date. We will not generate any operating revenues until after completion of our initial Business Combination. We generated non-operating income in the form of investment income from the investments held in the Trust Account following the closing of the Initial Public Offering.
For the three months ended September 30, 2022, we had net income of approximately $309,000, which consisted of approximately $1.1 million in interest income from investments held in the Trust Account, partially offset by approximately $798,000 in general and administrative expenses and $30,000 in administrative expenses-related party.
For the three months ended September 30, 2021, we had net income of approximately $4.8 million, which consisted of a nonoperating gain of approximately $5 million from the change in fair value of derivative warrant liabilities and income from investments held in Trust Account of approximately $4,000, partially offset by general and administrative expenses of approximately $132,000, including administrative expenses with related parties of $30,000.
For the nine months ended September 30, 2022, we had net income of approximately $8.3 million, which consisted of a non-operating gain of approximately $7.9 million from the changes in fair value of derivative warrant liabilities and approximately $1.6 million in interest income from investments held in the Trust Account, partially offset by approximately $1.1 million in general and administrative expenses and $90,000 in administrative expenses-related party.
23
Table of Contents
For the nine months ended September 30, 2021, we had net income of approximately $13.2 million, which consisted of a nonoperating gain of approximately $14 million from the change in fair value of derivative warrant liabilities and income from investments held in Trust Account of approximately $34,000, partially offset by general and administrative expenses of approximately $856,000, including administrative expenses with related parties of $90,000.
Contractual Obligations
We do not have any long-term debt obligations, capital lease obligations, operating lease obligations, purchase obligations or long-term liabilities.
We entered into an administrative services agreement pursuant to which we have agreed to pay our Sponsor a total of $10,000 per month for office space, utilities and administrative support. Upon completion of the Initial Business Combination or our liquidation, the agreement will terminate.
The underwriters of the Initial Public Offering were entitled to underwriting discounts and commissions of 5.5%, of which 2.0% (approximately $6.5 million) was paid at the closing of the Initial Public Offering and closing of sale of the Over-Allotment Units and 3.5% (approximately $11.3 million) was deferred. The deferred underwriting discounts and commissions will become payable to the underwriters upon the consummation of the Initial Business Combination and will be paid from the amounts held in the Trust Account. The underwriters are not entitled to any interest accrued on the deferred underwriting discounts and commissions.
Critical Accounting Policies
The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. A summary of our significant accounting policies is included in Note 2 to our condensed financial statements in Part I, Item 1 of this Quarterly Report. Certain of our accounting policies are considered critical, as these policies are the most important to the depiction of our condensed financial statements and require significant, difficult or complex judgments, often employing the use of estimates about the effects of matters that are inherently uncertain. Such policies are summarized in the Management’s Discussion and Analysis of Financial Condition and Results of Operations section in our 2021 Annual Report on Form 10-K filed with the SEC on March 21, 2022. There have been no significant changes in the application of our critical accounting policies during the nine months ended September 30, 2022.
Recent Accounting Pronouncements
See Note 2 to the unaudited condensed financial statements included in Part I, Item 1 of this Quarterly Report for a discussion of recent accounting pronouncements.
JOBS Act
The Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” and under the JOBS Act are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, the financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.
24
Table of Contents
Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the Chief Executive Officer’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our Initial Public Offering or until we are no longer an “emerging growth company,” whichever is earlier.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and are not required to provide the information otherwise required under this item.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended September 30, 2022, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial officer has concluded that during the period covered by this report, our disclosure controls and procedures were effective as of September 30, 2022.
Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting
There was no change in our internal control over financial reporting that occurred during the fiscal quarter ended September 30, 2022 covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
25
Table of Contents
PART II-OTHER INFORMATION
Item 1. Legal Proceedings
None
Item 1A. Risk Factors.
Our material risk factors are disclosed in “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K. Other than as set forth below, there have been no material changes from the risk factors previously disclosed in such filing. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risks could arise that may also affect our business or ability to consummate an initial business combination. We may disclose changes to such risk factors or disclose additional risk factors from time to time in our future filings with the SEC.
The current economic downturn may lead to increased difficulty in completing our initial business combination.
Our ability to consummate our initial business combination may depend, in part, on worldwide economic conditions. In recent months, we have observed increased economic uncertainty in the United States and abroad. Impacts of such economic weakness include:
• | falling overall demand for goods and services, leading to reduced profitability; |
• | reduced credit availability; |
• | higher borrowing costs; |
• | reduced liquidity; |
• | volatility in credit, equity and foreign exchange markets; and |
• | bankruptcies. |
These developments could lead to inflation, higher interest rates, and uncertainty about business continuity, which may adversely affect the business of our potential target businesses and create difficulties in obtaining debt or equity financing for our initial business combination, as well as leading to an increase in the number of public stockholders exercising redemption rights in connection therewith.
Recent volatility in capital markets and lower market prices for our securities may affect our ability to obtaining financing for our initial business combination through sales of shares of our common stock or issuance of indebtedness.
With uncertainty in the capital markets and other factors, financing for our initial business combination may not be available on terms favorable to us or at all. If we raise additional funds through further issuances of equity or convertible debt securities, our existing stockholders could suffer significant dilution, and any new equity securities we issue could have rights, preferences, and privileges superior to those of holders of our common stock. Any debt financing secured by us could involve additional restrictive covenants relating to our capital-raising activities and other financial and operational matters, which may limit the operations and growth of the surviving company of our initial business combination. If we are unable to obtain adequate financing or financing on terms satisfactory to us, we could face significant limitations on our ability to complete our initial business combination.
Changes to laws or regulations or in how such laws or regulations are interpreted or applied, or a failure to comply with any laws, regulations, interpretations or applications, may adversely affect our business, including our ability to negotiate and complete our initial business combination.
26
Table of Contents
We are subject to the laws and regulations, and interpretations and applications of such laws and regulations, of national, regional, state and local governments and non-U.S. jurisdictions. In particular, we are required to comply with certain SEC and potentially other legal and regulatory requirements, and our consummation of an initial business combination may be contingent upon our ability to comply with certain laws, regulations, interpretations and applications and any post-business combination company may be subject to additional laws, regulations, interpretations and applications. Compliance with, and monitoring of, the foregoing may be difficult, time consuming and costly. Those laws and regulations and their interpretation and application may also change from time to time, and those changes could have a material adverse effect on our business, including our ability to negotiate and complete an initial business combination. A failure to comply with applicable laws or regulations, as interpreted and applied, could have a material adverse effect on our business, including our ability to negotiate and complete an initial business combination.
On March 30, 2022, the SEC issued proposed rules (the “SPAC Rule Proposals”) relating, among other items, to disclosures in SEC filings in connection with business combination transactions involving special purpose acquisition companies (“SPACs”) and private operating companies; the financial statement requirements applicable to transactions involving shell companies; the use of projections in SEC filings in connection with proposed business combination transactions; the potential liability of certain participants in proposed business combination transactions; and the extent to which SPACs could become subject to regulation under the Investment Company Act, including a proposed rule that would provide SPACs a safe harbor from treatment as an investment company if they satisfy certain conditions that limit a SPAC’s duration, asset composition, business purpose and activities. Certain of the procedures that we, a potential Business Combination target, or others may determine to undertake in connection with the SPAC Rule Proposals, as proposed or as adopted, or pursuant to the SEC’s views expressed in the SPAC Rule Proposals, may increase the costs and time of negotiating and completing an initial business combination, and may constrain the circumstances under which we could complete an initial business combination.
How are the funds in the Trust Account currently being held?
The funds in the Trust Account have, since our IPO, been held only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds investing solely in U.S. government treasury obligations and meeting certain conditions under Rule 2a-7 under the Investment Company Act. However, to mitigate the risk of us being deemed to have been operating as an unregistered investment company (including under the subjective test of Section 3(a)(1)(A) of the Investment Company Act), we may, and likely will, on or prior to the 24-month anniversary of the effective date of the registration statement filed in connection with our IPO (the “IPO Registration Statement”), should our Company continue to exist to such date, instruct Continental, the trustee with respect to the Trust Account, to liquidate the U.S. government treasury obligations or money market funds held in the Trust Account and thereafter to hold all funds in the Trust Account in cash until the earlier of consummation of our initial business combination or liquidation. As a result, following such liquidation, we will likely receive minimal interest, if any, on the funds held in the Trust Account, which would reduce the dollar amount our public shareholders would receive upon any redemption or liquidation of the Company.
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities |
None.
Item 3. | Defaults Upon Senior Securities |
None.
Item 4. | Mine Safety Disclosures |
Not applicable.
Item 5. | Other Information |
None.
27
Table of Contents
Item 6. | Exhibits |
* | These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing. |
28
Table of Contents
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: November 14, 2022 | PRIME IMPACT ACQUISITION I | |||||
By: | /s/ Michael Cordano | |||||
Name: | Michael Cordano | |||||
Title: | Co-Chief Executive Officer | |||||
(Principal Executive Officer) | ||||||
By: | /s/ Mark Long | |||||
Name: | Mark Long | |||||
Title: | Co-Chief Executive Officer and Chief Financial Officer | |||||
(Principal Financial and Accounting Officer) |
29